Characterization of a SARS-CoV-2 Omicron BA.5 direct-contact transmission model in hamsters

Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523 (2020).

Article 
PubMed 
PubMed Central 

Google Scholar 

Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).

Article 
PubMed 
PubMed Central 

Google Scholar 

Yuan, S. et al. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters. Science 377, 428–433 (2022).

Article 
PubMed 

Google Scholar 

Lin, L., Liu, Y., Tang, X. & He, D. The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern. Front. Public Health 9, 775224 (2021).

Article 
PubMed 
PubMed Central 

Google Scholar 

Shrestha, L. B., Foster, C., Rawlinson, W., Tedla, N. & Bull, R. A. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev. Med. Virol. 32, e2381 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Hoffmann, M. et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell 185, 447–456 e411 (2022).

Article 
PubMed 

Google Scholar 

Jung, C. et al. Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning? J. Virol. 96, e0207721 (2022).

Article 
PubMed 

Google Scholar 

WHO (World Health Organization), Tracking SARS-CoV-2 Variants (2024).

Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671–675 (2022).

Article 
PubMed 

Google Scholar 

Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657–663 (2022).

Article 
PubMed 

Google Scholar 

VanBlargan, L. A. et al. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat. Med. 28, 490–495 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Schmitz, K. S. et al. Potency of Fusion-inhibitory lipopeptides against SARS-CoV-2 variants of concern. mBio 13, e0124922 (2022).

Article 
PubMed 

Google Scholar 

Dillard, J. A., Martinez, S. A., Dearing, J. J., Montgomery, S. A. & Baxter, V. K. Animal Models for the study of SARS-CoV-2-induced respiratory disease and pathology. Comp. Med. 73, 72–90 (2023).

Article 
PubMed 
PubMed Central 

Google Scholar 

Munoz-Fontela, C. et al. Animal models for COVID-19. Nature 586, 509–515 (2020).

Article 
PubMed 
PubMed Central 

Google Scholar 

Tiwari, S., Goel, G. & Kumar, A. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19. Int. Rev. Immunol. 43, 13–32 (2024).

Article 
PubMed 

Google Scholar 

Zhang, J., Rissmann, M., Kuiken, T. & Haagmans, B. L. Comparative Pathogenesis of Severe Acute Respiratory Syndrome Coronaviruses. Annu Rev Pathol 19, 423–451 (2024).

Article 
PubMed 

Google Scholar 

McCray, P. B. Jr. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813–821 (2007).

Article 
PubMed 

Google Scholar 

Wan, Y., Shang, J., Graham, R., Baric, R. S. & Li, F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 94, (2020).

Chan, J. F. et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis 71, 2428–2446 (2020).

Article 
PubMed 

Google Scholar 

Casel, M. A. B., Rollon, R. G. & Choi, Y. K. Experimental animal models of coronavirus infections: strengths and limitations. Immune Netw. 21, e12 (2021).

Article 
PubMed 
PubMed Central 

Google Scholar 

Stadnytskyi, V., Bax, C. E., Bax, A. & Anfinrud, P. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc. Natl Acad. Sci. USA 117, 11875–11877 (2020).

Article 
PubMed 
PubMed Central 

Google Scholar 

Sia, S. F. et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834–838 (2020).

Article 
PubMed 
PubMed Central 

Google Scholar 

Uraki, R. et al. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents. Nature 612, 540–545 (2022).

Article 
PubMed 

Google Scholar 

Su, W. et al. Reduced pathogenicity and transmission potential of omicron BA.1 and BA.2 sublineages compared with the early severe acute respiratory syndrome coronavirus 2 D614G variant in Syrian hamsters. J Infect Dis 227, 1143–1152 (2023).

Article 
PubMed 

Google Scholar 

de Vries, R. D. et al. Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science 371, 1379–1382 (2021).

Article 
PubMed 
PubMed Central 

Google Scholar 

van Doornum, G. J., Schutten, M., Voermans, J., Guldemeester, G. J. & Niesters, H. G. Development and implementation of real-time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens. J. Med. Virol. 79, 1868–1876 (2007).

Article 
PubMed 

Google Scholar 

Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25, (2020).

Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493–497 (1938).

Article 

Google Scholar 

Rockx, B. et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 368, 1012–1015 (2020).

Article 
PubMed 
PubMed Central 

Google Scholar 

Haagmans, B. L. et al. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a Hamster model. J. Infect. Dis. 223, 2020–2028 (2021).

Article 
PubMed 

Google Scholar 

Rosenke, K. et al. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg. Microbes Infect. 9, 2673–2684 (2020).

Article 
PubMed 
PubMed Central 

Google Scholar 

Port, J. R. et al. Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster. Elife 12, (2024).

Cox, R. M. et al. Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models. Nat. Commun. 14, 4731 (2023).

Article 
PubMed 
PubMed Central 

Google Scholar 

Yamasoba, D. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell 185, 2103–2115 e2119 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Abdelnabi, R. et al. Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters. EBioMedicine 68, 103403 (2021).

Article 
PubMed 
PubMed Central 

Google Scholar 

Patel, D. R. et al. Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model. Microbiol. Spectr. 12, e0499822 (2024).

Article 
PubMed 

Google Scholar 

O’Neill, A. et al. Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern. EBioMedicine 99, 104924 (2024).

Article 
PubMed 

Google Scholar 

Knott, D. et al. Use of a preclinical natural transmission model to study antiviral effects of a carbohydrate-binding module therapy against SARS-CoV-2 in hamsters. Viruses 15, (2023).

Yuan, L. et al. Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster. Signal Transduct. Target Ther. 6, 136 (2021).

Article 
PubMed 
PubMed Central 

Google Scholar 

Dhakal, S. et al. Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model. mBio 12, e0097421 (2021).

Article 
PubMed 

Google Scholar 

Castellan, M. et al. Host Response of Syrian hamster to SARS-CoV-2 infection including differences with humans and between sexes. Viruses 15, (2023).

Solis, O. et al. The SARS-CoV-2 spike protein binds and modulates estrogen receptors. Sci. Adv. 8, eadd4150 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Yuan, L. et al. Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model. Signal Transduct. Target Ther. 7, 47 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Uraki, R. et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2. Nature 607, 119–127 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Osterrieder, N. et al. Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters. Viruses 12 (2020).

Huo, J. et al. A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat. Commun. 12, 5469 (2021).

Article 
PubMed 
PubMed Central 

Google Scholar 

Song, Z. et al. SARS-CoV-2 causes a systemically multiple organs damages and dissemination in Hamsters. Front. Microbiol. 11, 618891 (2020).

Article 
PubMed 

Google Scholar 

Zhao, H. et al. A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters. Cell Discov. 8, 62 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Port, J. R. et al. Augmentation of Omicron BA.1 pathogenicity in hamsters using intratracheal inoculation. npj Viruses 2, 3 (2024).

Article 

Google Scholar 

Forero, C. et al. Volume-associated clinical and histopathological effects of intranasal instillation in Syrian Hamsters: considerations for infection and therapeutic studies. Pathogens 11, (2022).

Handley, A. et al. SARS-CoV-2 disease severity in the golden Syrian Hamster model of infection is related to the volume of intranasal inoculum. Viruses 15, (2023).

Moore, I. N. et al. Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume. J. Virol. 88, 13879–13891 (2014).

Article 
PubMed 
PubMed Central 

Google Scholar 

Miller, D. S., Kok, T. & Li, P. The virus inoculum volume influences outcome of influenza A infection in mice. Lab. Anim. 47, 74–77 (2013).

Article 
PubMed 

Google Scholar 

Southam, D. S., Dolovich, M., O’Byrne, P. M. & Inman, M. D. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L833–L839 (2002).

Article 
PubMed 

Google Scholar 

Miller, M. A. et al. Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia. PLoS ONE 7, e31359 (2012).

Article 
PubMed 
PubMed Central 

Google Scholar 

Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715–720 (2022).

Article 
PubMed 

Google Scholar 

Chu, H., Chan, J. F. & Yuen, K. Y. Animal models in SARS-CoV-2 research. Nat. Methods 19, 392–394 (2022).

Article 
PubMed 

Google Scholar 

Port, J. R. et al. SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters. Nat. Commun. 12, 4985 (2021).

Article 
PubMed 
PubMed Central 

Google Scholar 

Ganti, K. et al. Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission. PLoS Pathog. 18, e1010181 (2022).

Article 
PubMed 
PubMed Central 

Google Scholar 

Xu, C., Wang, J., Yu, L., Sui, X. & Wu, Q. Omicron subvariant BA.5 is highly contagious but containable: successful experience from Macau. Front. Public Health 10, 1029171 (2022).

Article 
PubMed 

Google Scholar 

Gattermann, R. et al. Golden hamsters are nocturnal in captivity but diurnal in nature. Biol Lett 4, 253–255 (2008).

Article 
PubMed 
PubMed Central 

Google Scholar 

Abdelnabi, R. et al. Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment. Nat. Commun. 14, 2124 (2023).

Article 
PubMed 
PubMed Central 

Google Scholar 

Rizvi, Z. A. et al. Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection. Elife 11, (2022).

Sasaki, M. et al. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model. EBioMedicine 99, 104950 (2024).

Article 
PubMed 

Google Scholar